Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mylan Inc's Mylan Laboratories Limited bags INR683-Crore (INR6.83 Billion) Order From South Africa-Business Standard


Sunday, 2 Dec 2012 01:59pm EST 

Business Standard reported that Mylan Laboratories Limited, the Indian subsidiary of Mylan Inc, has been selected as one of the suppliers of anti-retroviral (ARV) drugs for treating HIV patients to the South African health department for a two-year period starting January 1, 2013. The Company, through South African subsidiary Mylan Limited, has secured a Rand 1.12-billion (INR683 crore) order, representing 19.1% of the total tender value.